Correlation Between Merus BV and AnaptysBio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Merus BV and AnaptysBio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merus BV and AnaptysBio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Merus BV and AnaptysBio, you can compare the effects of market volatilities on Merus BV and AnaptysBio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merus BV with a short position of AnaptysBio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merus BV and AnaptysBio.

Diversification Opportunities for Merus BV and AnaptysBio

0.31
  Correlation Coefficient

Weak diversification

The 3 months correlation between Merus and AnaptysBio is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Merus BV and AnaptysBio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AnaptysBio and Merus BV is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merus BV are associated (or correlated) with AnaptysBio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AnaptysBio has no effect on the direction of Merus BV i.e., Merus BV and AnaptysBio go up and down completely randomly.

Pair Corralation between Merus BV and AnaptysBio

Given the investment horizon of 90 days Merus BV is expected to generate 5.97 times less return on investment than AnaptysBio. But when comparing it to its historical volatility, Merus BV is 2.48 times less risky than AnaptysBio. It trades about 0.05 of its potential returns per unit of risk. AnaptysBio is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  1,304  in AnaptysBio on December 27, 2024 and sell it today you would earn a total of  515.00  from holding AnaptysBio or generate 39.49% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Merus BV  vs.  AnaptysBio

 Performance 
       Timeline  
Merus BV 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Merus BV are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Merus BV may actually be approaching a critical reversion point that can send shares even higher in April 2025.
AnaptysBio 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in AnaptysBio are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite somewhat inconsistent basic indicators, AnaptysBio sustained solid returns over the last few months and may actually be approaching a breakup point.

Merus BV and AnaptysBio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Merus BV and AnaptysBio

The main advantage of trading using opposite Merus BV and AnaptysBio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merus BV position performs unexpectedly, AnaptysBio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AnaptysBio will offset losses from the drop in AnaptysBio's long position.
The idea behind Merus BV and AnaptysBio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Complementary Tools

Bonds Directory
Find actively traded corporate debentures issued by US companies
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Fundamental Analysis
View fundamental data based on most recent published financial statements
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets